🇺🇸 Sensipar® in United States

FDA authorised Sensipar® on 8 March 2004

Marketing authorisations

FDA — authorised 8 March 2004

  • Application: NDA021688
  • Marketing authorisation holder: AMGEN
  • Local brand name: SENSIPAR
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Status: approved

Sensipar® in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Sensipar® approved in United States?

Yes. FDA authorised it on 8 March 2004; FDA has authorised it.

Who is the marketing authorisation holder for Sensipar® in United States?

AMGEN holds the US marketing authorisation.